710 Medtronic Parkway, NE
Medtronic, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world.
Founders: Earl Bakken and Palmer Hermundlie
CEO: Omar Ishrak
CFO: Karen Parkhill
CSO (Scientific): Richard Kuntz
Please click here for Medtronic job opportunities.
Tweets by Medtronic
2219 articles with Medtronic
Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2021, which ended October 30, 2020 . The company reported second quarter worldwide rev
The New England Journal of Medicine: Medtronic Cryoablation is a Superior Treatment Option for Symptomatic Paroxysmal Atrial Fibrillation Compared to Drug Therapy
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical trial have been published in the New Eng
Acquisition Expands Medtronic's Artificial Intelligence and Data Capabilities, Becoming the First Company to Offer an Integrated Spine Solution Including AI-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery
Medtronic plc, the global leader in medical technology, announced that it has been recognized as one of the world's leading companies for sustainability with its inclusion in the Dow Jones Sustainability North America Index.
Medtronic Receives Health Canada Licence for the First-of-Its-Kind Percept™ PC Neurostimulator with Brainsense™ Technology
Next-Generation Technology Makes Percept™ the First and Only DBS System with Ability to Capture Patient-Specific Brain Signals for More Personalized, Data-Driven Treatment
10/29/2020Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Titan Medical Announces Achievement of $10 Million Technical Milestone Under Medtronic Development and License Agreement
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI) , a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed the first technical milestone under the development and license agreement with Medtronic plc (“Medtronic”) (NYSE: MDT), and is due to receive a U.S. $10 million payment. The development and l
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ venous self-expanding stent system. This device is
Nine-Month Results from Medtronic IN.PACT BTK Study Presented in Late-Breaking Clinical Trial Sessions at TCT Connect Annual Meeting
Feasibility Study of Medtronic Drug-Coated Balloon Technology for Challenging Below-the-Knee Disease Shows Promise in Patients with Critical Limb Ischemia
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut™ TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients
Medtronic plc, the global leader in medical technology, will outline the company's strategy for driving accelerated revenue growth and sustainable double-digit total shareholder returns at its virtual 2020 Investor Day.
Medtronic plc, the global leader in medical technology, has been named one of America's most JUST companies, ranking 29th overall on the 'Forbes JUST 100' list for 2021 and first in its industry category of Healthcare Equipment and Services.
Medtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair Technology
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a partnership with The Foundry – a medical device company incubator – dating back to mid-2017 to invest in and create a company with the goal of developing an innovat
Medtronic 2020 Integrated Performance Report Shares Goal of Carbon Neutrality by FY30, Achievement of 100% Gender Pay Equity in the U.S., and Progress on COVID-19 Response
Medtronic plc (NYSE:MDT) today released its fiscal year 2020 (FY20) Integrated Performance Report: Putting Purpose Into Action . The report shares the company's approach to its most significant environmental, social, a
Medtronic Announces Adaptix™ Interbody System, the First Navigated Titanium Cage with Titan nanoLOCK™ Surface Technology
A World's First That Combines Innovative Technologies: Titan nanoLOCK™ Surface Technology and Navigation
Omar Ishrak to Retire as Medtronic Executive Chairman and Chairman of the Board; Geoff Martha to Succeed Ishrak as Chairman of the Board, Effective December 11, 2020
Medtronic plc announced that Omar Ishrak has decided not to stand for re-election at the Annual General Meeting in December and will retire as Executive Chairman and Chairman of its Board of Directors effective December 11, 2020.
Medtronic Resolute Onyx™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients
Medtronic plc, the global leader in medical technology, announced it has received U.S. Food and Drug Administration approval for new one-month of dual-antiplatelet therapy labeling with an expanded indication for high bleeding risk patients implanted with the Resolute Onyx™ DES.
Avenu's Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic's Commitment to Improving Outcomes for Patients with End-Stage Renal Disease DUBLIN , Sept. 30, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of Aven
Medtronic Announces Closing of Public Offering of €6.25 Billion of Senior Notes and Redemption of Outstanding Senior Notes
The net proceeds from the Offering are approximately €6.2 billion, after deducting underwriting discounts and commissions and estimated expenses related to the Offering payable by Medtronic Luxco.
U.S. Patent and Trademark Office Rejects IPR Challenge to Medtronic Patent Company Says No Final Determinations Have Been Made on Other Patents [25-September-2020] DUBLIN , Sept. 25, 2020 /PRNewswire/ -- Medtronic (NYSE:MDT) has won an important victory in a patent dispute over intellectual property for its sacral neuromodulation device family, the InterStim